Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hutchinson, G R
Parker, S
Pryor, J A
Duncan-Skingle, F
Hoffman, P N
Hodson, M E
Kaufmann, M E
and
Pitt, T L
1996.
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
Journal of Clinical Microbiology,
Vol. 34,
Issue. 3,
p.
584.
Govan, J R
and
Deretic, V
1996.
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Microbiological Reviews,
Vol. 60,
Issue. 3,
p.
539.
Vu-Thien, H.
Moissenet, D.
Valcin, M.
Dulot, C.
Tournier, G.
and
Garbarg-Chenon, A.
1996.
Molecular epidemiology ofBurkholderia cepacia, Stenotrophomonas maltophilia, andAlcaligenes xylosoxidans in a cystic fibrosis center.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 15,
Issue. 11,
p.
876.
Cimolai, Nevio
and
Trombley, Colleen
1996.
Enterobacterial intergenic consensus sequence polymerase chain reaction as a typing method for Burkholderia (Pseudomonas) cepacia.
Clinical Microbiology and Infection,
Vol. 2,
Issue. 1,
p.
59.
Humphreys, H.
and
Peckham, D.
1996.
Environmental sampling to detectBurkholderia cepacia in a cystic fibrosis outpatient clinic.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 15,
Issue. 6,
p.
523.
Monteil, H
and
Harf-Monteil, C
1997.
Aerobic gram-negative bacilli: newer nosocomial pathogens.
International Journal of Antimicrobial Agents,
Vol. 8,
Issue. 4,
p.
217.
Renders, N.H.M.
Sijmons, M.A.F.
Belkum, A.van
Overbeek, S.E.
Mouton, J.W.
and
Verbrugh, H.A.
1997.
Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings.
Research in Microbiology,
Vol. 148,
Issue. 5,
p.
447.
Denton, Miles
and
Kerr, Kevin G.
1998.
Microbiological and Clinical Aspects of Infection Associated with
Stenotrophomonas maltophilia
.
Clinical Microbiology Reviews,
Vol. 11,
Issue. 1,
p.
57.
Wigley, P.
and
Burton, N. F.
1999.
Genotypic and phenotypic relationships in Burkholderia cepacia isolated from cystic fibrosis patients and the environment.
Journal of Applied Microbiology,
Vol. 86,
Issue. 3,
p.
460.
Miller, Suzanne C. M.
LiPuma, John J.
and
Parke, Jennifer L.
2002.
Culture-Based and Non-Growth-Dependent Detection of the
Burkholderia cepacia
Complex in Soil Environments
.
Applied and Environmental Microbiology,
Vol. 68,
Issue. 8,
p.
3750.
Saiman, Lisa
and
Siegel, Jane
2003.
Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission.
Infection Control & Hospital Epidemiology,
Vol. 24,
Issue. S5,
p.
S6.
Döring, Gerd
and
Hoiby, Niels
2004.
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus.
Journal of Cystic Fibrosis,
Vol. 3,
Issue. 2,
p.
67.
Saiman, Lisa
and
Siegel, Jane
2004.
Infection Control in Cystic Fibrosis.
Clinical Microbiology Reviews,
Vol. 17,
Issue. 1,
p.
57.
Estivariz, Concepcion F.
Bhatti, Lubna I.
Pati, Ritu
Jensen, Bette
Arduino, Matthew J.
Jernigan, Daniel
LiPuma, John J.
and
Srinivasan, Arjun
2006.
An Outbreak of Burkholderia cepacia Associated With Contamination of Albuterol and Nasal Spray.
Chest,
Vol. 130,
Issue. 5,
p.
1346.
Boronat García, Miguel
Abenza Baeza, Salomé
Martínez-Toldos, Carmen
and
Yagüe Guirao, Genoveva
2008.
Queratitis por Burkholderia cepacia.
Medicina Clínica,
Vol. 131,
Issue. 15,
p.
599.
Avgeri, Sophia G.
Matthaiou, Dimitrios K.
Dimopoulos, George
Grammatikos, Alexandros P.
and
Falagas, Matthew E.
2009.
Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence.
International Journal of Antimicrobial Agents,
Vol. 33,
Issue. 5,
p.
394.
Pitt, Tyrone L.
and
Dance, David A.
2010.
Topley & Wilson's Microbiology and Microbial Infections.
LiPuma, John J.
2010.
The Changing Microbial Epidemiology in Cystic Fibrosis.
Clinical Microbiology Reviews,
Vol. 23,
Issue. 2,
p.
299.
Russell, Alistair B.
Hood, Rachel D.
Bui, Nhat Khai
LeRoux, Michele
Vollmer, Waldemar
and
Mougous, Joseph D.
2011.
Type VI secretion delivers bacteriolytic effectors to target cells.
Nature,
Vol. 475,
Issue. 7356,
p.
343.
Ku, Nam Su
Han, Sang Hoon
Kim, Chang Oh
Baek, Ji-Hyeon
Jeong, Su Jin
Jin, Sung Joon
Choi, Jun Yong
Song, Young Goo
and
Kim, June Myung
2011.
Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia.
Scandinavian Journal of Infectious Diseases,
Vol. 43,
Issue. 10,
p.
792.